Identification of Family-Specific Features in Cas9 and Cas12 Proteins: A Machine Learning Approach Using Complete

Sita Sirisha Madugula1, Pranav Pujar2, Nammi Bharani2

  • 1Department of Pharmaceutical Sciences, University of North Texas System College of Pharmacy, University of North Texas Health Science Center, Fort Worth, Texas, United States.

Insights

Researchers identified key protein features distinguishing Cas12 and Cas9 gene editing systems. This discovery aids in understanding their catalytic mechanisms and designing improved CRISPR-Cas tools for genetic diseases.

Area of Science:

  • Biotechnology and Genetic Engineering
  • Computational Biology and Bioinformatics

Background:

  • CRISPR-Cas technology offers gene-level defect correction for genetic diseases, utilizing Cas proteins as nucleases guided by RNA.
  • Limitations of current Cas proteins (e.g., Cas9) include large size, low efficiency, and off-target effects, necessitating the discovery of novel variants.
  • Understanding the distinct features of Cas protein families is crucial for developing improved gene editing tools.

Approach:

  • Developed Random Forest (RF) binary classifiers to differentiate Cas12 and Cas9 from non-Cas proteins using 13,495 features.
  • Constructed multiclass RF classifiers to distinguish between Cas9, Cas12, and non-Cas proteins.
  • Validated model performance on test and independent datasets, achieving high accuracy (95% for Cas12, 97% for Cas9) and F1 score (0.97 for multiclass).

Key Points:

  • Identified specific protein descriptors crucial for distinguishing Cas12 (e.g., Schneider-lag, charge, volume, polarizability) and Cas9 (e.g., Tripeptide Composition - TPC) families.
  • Discovered conserved tripeptides (PWN, PYY, HHA, DHI) in Cas9, with HHA and DHI linked to DNA cleavage activity.
  • Proposed PWN and PYY as potentially essential for Cas9 family function.

Conclusions:

  • The study elucidates unique protein attributes differentiating Cas9 and Cas12 families.
  • Identified key descriptors provide insights into the catalytic mechanisms of Cas9 and Cas12.
  • Findings facilitate the design of novel Cas systems with enhanced gene-editing properties for therapeutic applications.